CMS has determined that the 1332 waiver applications recently submitted by Colorado and North Dakota are complete and has opened the federal public comment period through July 5.

Senators and stakeholders on Tuesday (June 18) said parts of the Senate health committee’s bipartisan package to lower health costs would particularly help rural areas, including provisions on maternal health and telemedicine, but some said more could be done.

FDA has expanded its patent certification list to include additional data that can help subsequent generic drug applicants determine when their products can be approved and marketed, the agency announced Tuesday (June 18).

American Hospital Association Executive Vice President Tom Nickels said the group plans to make information from 1,100 hospitals on how they use the 340B drug discount program public and to share information from AHA’s voluntary transparency initiative with the Health Resources and Services Administration.

Senate health committee Chair Lamar Alexander (R-TN) told Sen. Robert Casey (D-PA) and the rest of the health committee he is committed to finding a path forward for over-the-counter drug monograph reform legislation that has stalled in the Senate.

Some biologics experts are perplexed by the Trump administration’s argument that subjecting biologics products to United States Pharmacopeia (USP) monographs would hamper innovation.

Americans for Safe Access and data company Aurelius Data Inc. have partnered to develop a research platform that will compile use, perception and biometric data on consumers who are using cannabis products to help their medical conditions, and will make those insights available in a subscription-based database that allows users to see what regimens patients are using.

Senate health committee Chair Lamar Alexander (R-TN) said Tuesday (June 18) that his committee will mark up its bipartisan legislation to lower health costs next week.